e-Drug3D

933

RAMELTEON


INN
RAMELTEON

cas 196597-26-9
CLASS

NERVOUS SYSTEM
HYPNOTICS
SEDATIVES
TREATMENT OF INSOMNIA
AGONIST

ROUTE (list)

ORAL

ATC code

N05CH02

PK parameters

F 1.8 PERCENT
Tmax 0.75 HOUR
VD 73.6 LITER
Cl 28.3 LITER / HOUR (EQN)
PPB 82 PERCENT
t1/2 1.8 HOUR

Solubility

VERY SLIGHTLY SOLUBLE IN WATER


Target

TARGET MELATONIN RECEPTOR MT1
MELATONIN RECEPTOR MT2

PDB
6ME2 (XFEL CRYSTAL STRUCTURE OF HUMAN MELATONIN RECEPTOR MT1 IN COMPLEX WITH RAMELTEON)

Ligand code = JEV (link to the list of PDB complexes)

Download experimental 3D coordinates of JEV with added hydrogens

DrugCentral

Melatonin receptor type 1A UNIPROT P48039 MTNR1A

Melatonin receptor type 1B UNIPROT P49286 MTNR1B

Download SDF file N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzoxol-8-yl]ethyl]propanamide

Formula:
C16H21NO2

Calculated chemical properties:

MW 259.34
NB_atoms 19
XLogP 2.57
PSA 40.205
NB_HD 1
NB_HA 3
fsp3 0.56
Lipinski(0=no;1=yes) 1

FDA
NDA 021782 (pdf not found) INN (RAMELTEON) ROZEREM (TAKEDA PHARMS USA) APPROVAL= AP YEAR= 2005
NDA 091693 (pdf not found) INN (RAMELTEON) RAMELTEON (DR REDDYS LABS SA) APPROVAL= AP YEAR= 2013
NDA 091610 (pdf not found) INN (RAMELTEON) RAMELTEON (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2015
NDA 211567 (pdf not found) INN (RAMELTEON) RAMELTEON (ZYDUS PHARMS) APPROVAL= AP YEAR= 2019
NDA 212650 (pdf not found) INN (RAMELTEON) RAMELTEON (I3 PHARMS) APPROVAL= AP YEAR= 2020
NDA 213186 (pdf not found) INN (RAMELTEON) RAMELTEON (GRANULES) APPROVAL= AP YEAR= 2020
NDA 213815 (pdf not found) INN (RAMELTEON) RAMELTEON (APPCO) APPROVAL= AP YEAR= 2020
NDA 215435 (pdf not found) INN (RAMELTEON) RAMELTEON (ANDAS 5 HOLDING) APPROVAL= AP YEAR= 2022
NDA 216209 (pdf not found) INN (RAMELTEON) RAMELTEON (XIROMED) APPROVAL= AP YEAR= 2022
NDA 215243 (pdf not found) INN (RAMELTEON) RAMELTEON (MICRO LABS) APPROVAL= AP YEAR= 2023
NDA 215972 (pdf not found) INN (RAMELTEON) RAMELTEON (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL